161 related articles for article (PubMed ID: 28530069)
1. [IN-OFFICE VOCAL CORD INJECTION FOR TREATMENT OF DYSPHONIA].
Benyamini L; Awwad F; Gil Z; Cohen JT
Harefuah; 2016 Nov; 155(11):656-659. PubMed ID: 28530069
[TBL] [Abstract][Full Text] [Related]
2. Voice Outcomes following a Single Office-Based Steroid Injection for Vocal Fold Scar.
Young WG; Hoffman MR; Koszewski IJ; Whited CW; Ruel BN; Dailey SH
Otolaryngol Head Neck Surg; 2016 Nov; 155(5):820-828. PubMed ID: 27507145
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of a Shorter Follow-up Time to Capture Benefit of a Trial Vocal Fold Augmentation.
Carroll TL; Faudoa E; Van Doren M
J Voice; 2019 Mar; 33(2):169-175. PubMed ID: 29373176
[TBL] [Abstract][Full Text] [Related]
4. Voice outcome after vocal fold injection augmentation with carboxymethyl cellulose versus calcium hydroxyapatite.
Cohen JT; Benyamini L
J Laryngol Otol; 2020 Mar; 134(3):263-269. PubMed ID: 32127077
[TBL] [Abstract][Full Text] [Related]
5. Comparison of long-term voice outcomes after vocal fold augmentation using autologous fat injection by direct microlaryngoscopy versus office-based calcium hydroxylapatite injection.
Zeleník K; Walderová R; Kučová H; Jančatová D; Komínek P
Eur Arch Otorhinolaryngol; 2017 Aug; 274(8):3147-3151. PubMed ID: 28478500
[TBL] [Abstract][Full Text] [Related]
6. Clinical evaluation of Parkinson's-related dysphonia.
Sewall GK; Jiang J; Ford CN
Laryngoscope; 2006 Oct; 116(10):1740-4. PubMed ID: 17003722
[TBL] [Abstract][Full Text] [Related]
7. Using Trial Vocal Fold Injection to Select Vocal Fold Scar Patients Who May Benefit From More Durable Augmentation.
Carroll TL; Dezube A; Bauman LA; Mallur PS
Ann Otol Rhinol Laryngol; 2018 Feb; 127(2):105-112. PubMed ID: 29231041
[TBL] [Abstract][Full Text] [Related]
8. Treatment of Patients with Vocal Fold Atrophy and Comorbid Essential Voice Tremor: Long-Term Injection Augmentation Outcomes After Successful Diagnostic Vocal Fold Injection Augmentation.
Van Doren M; Faudoa E; Carroll TL
J Voice; 2020 May; 34(3):471-476. PubMed ID: 30503608
[TBL] [Abstract][Full Text] [Related]
9. Type I gore-tex laryngoplasty for glottic incompetence in mobile vocal folds.
Buckmire RA; Bryson PC; Patel MR
J Voice; 2011 May; 25(3):288-92. PubMed ID: 20236795
[TBL] [Abstract][Full Text] [Related]
10. An Analysis of the Effects of Voice Therapy on Patients With Early Vocal Fold Polyps.
Zhuge P; You H; Wang H; Zhang Y; Du H
J Voice; 2016 Nov; 30(6):698-704. PubMed ID: 26403648
[TBL] [Abstract][Full Text] [Related]
11. Intracordal Injection of Basic Fibroblast Growth Factor in 100 Cases of Vocal Fold Atrophy and Scar.
Hirano S; Sugiyama Y; Kaneko M; Mukudai S; Fuse S; Hashimoto K
Laryngoscope; 2021 Sep; 131(9):2059-2064. PubMed ID: 33107605
[TBL] [Abstract][Full Text] [Related]
12. Trial Vocal Fold Injection Predicts Thyroplasty Outcomes in Nonparalytic Glottic Incompetence.
Dumberger LD; Overton L; Buckmire RA; Shah RN
Ann Otol Rhinol Laryngol; 2017 Apr; 126(4):279-283. PubMed ID: 28100072
[TBL] [Abstract][Full Text] [Related]
13. Safety and efficacy of carboxymethylcellulose in the treatment of glottic insufficiency.
Mallur PS; Morrison MP; Postma GN; Amin MR; Rosen CA
Laryngoscope; 2012 Feb; 122(2):322-6. PubMed ID: 22258817
[TBL] [Abstract][Full Text] [Related]
14. Office-based Autologous Fat Injection Laryngoplasty for Vocal Process Granuloma.
Hu HC; Hung YT; Lin SY; Chang SY
J Voice; 2016 Nov; 30(6):758.e7-758.e11. PubMed ID: 26454769
[TBL] [Abstract][Full Text] [Related]
15. Interarytenoid muscle botox injection for treatment of adductor spasmodic dysphonia with vocal tremor.
Kendall KA; Leonard RJ
J Voice; 2011 Jan; 25(1):114-9. PubMed ID: 20137891
[TBL] [Abstract][Full Text] [Related]
16. Voice outcomes of polyacrylamide hydrogel injection laryngoplasty.
Lee SW; Son YI; Kim CH; Lee JY; Kim SC; Koh YW
Laryngoscope; 2007 Oct; 117(10):1871-5. PubMed ID: 17690620
[TBL] [Abstract][Full Text] [Related]
17. Structure and Function of the Vocal Cords after Airway Reconstruction on Magnetic Resonance Imaging.
Elders BBLJ; Hakkesteegt MM; Ciet P; Tiddens HAWM; Wielopolski P; Pullens B
Laryngoscope; 2021 Jul; 131(7):E2402-E2408. PubMed ID: 33459361
[TBL] [Abstract][Full Text] [Related]
18. Botulinum toxin treatment of false vocal folds in adductor spasmodic dysphonia: Functional outcomes.
Simpson CB; Lee CT; Hatcher JL; Michalek J
Laryngoscope; 2016 Jan; 126(1):118-21. PubMed ID: 26467807
[TBL] [Abstract][Full Text] [Related]
19. Functional outcomes of endoscopic arytenoid abduction lateropexy for unilateral vocal cord paralysis with dyspnea.
Matievics V; Bach A; Sztano B; Bere Z; Tobias Z; Castellanos PF; Mueller AH; Rovo L
Eur Arch Otorhinolaryngol; 2017 Oct; 274(10):3703-3710. PubMed ID: 28791468
[TBL] [Abstract][Full Text] [Related]
20. Comparative analysis on the efficiency of the injection laryngoplasty technique using calcium hydroxyapatite (CaHA): the thyrohyoid approach versus the cricothyroid approach.
Woo SH; Son YI; Lee SH; Park JJ; Kim JP
J Voice; 2013 Mar; 27(2):236-41. PubMed ID: 23280385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]